X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (138) 138
index medicus (94) 94
hematology (87) 87
multiple myeloma - genetics (71) 71
multiple myeloma (67) 67
multiple myeloma - pathology (51) 51
oncology (51) 51
multiple myeloma - drug therapy (45) 45
animals (43) 43
female (40) 40
mice (40) 40
abridged index medicus (38) 38
male (35) 35
multiple-myeloma (34) 34
article (31) 31
bortezomib (29) 29
multiple myeloma - metabolism (28) 28
middle aged (26) 26
aged (25) 25
cancer (25) 25
translocation, genetic (25) 25
tumor cells, cultured (23) 23
stem-cell transplantation (22) 22
research (21) 21
disease progression (20) 20
gene expression regulation, neoplastic (20) 20
lymphoid neoplasia (20) 20
cell line, tumor (19) 19
prognosis (19) 19
risk factors (19) 19
thalidomide - analogs & derivatives (19) 19
treatment outcome (19) 19
adult (18) 18
antineoplastic agents - therapeutic use (18) 18
cell biology (18) 18
dexamethasone - administration & dosage (18) 18
apoptosis (17) 17
genetic aspects (17) 17
multiple myeloma - therapy (17) 17
aged, 80 and over (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
mouse model (16) 16
multiple myeloma - mortality (16) 16
care and treatment (15) 15
expression (15) 15
multiple myeloma - immunology (15) 15
undetermined significance (15) 15
activation (14) 14
gene expression profiling (14) 14
in situ hybridization, fluorescence (14) 14
lenalidomide (14) 14
monoclonal gammopathy (14) 14
thalidomide (14) 14
thalidomide - administration & dosage (14) 14
health aspects (13) 13
high-dose therapy (13) 13
immunoglobulin heavy chains - genetics (13) 13
immunology (13) 13
mice, inbred c57bl (13) 13
survival rate (13) 13
therapy (13) 13
multiple myeloma - diagnosis (12) 12
mutation (12) 12
proteins (12) 12
recurrence (12) 12
bone-marrow (11) 11
cells (11) 11
clinical trials and observations (11) 11
dexamethasone (11) 11
diagnosis (11) 11
lenalidomide plus dexamethasone (11) 11
molecular sequence data (11) 11
survival (11) 11
tumors (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
development and progression (10) 10
gene (10) 10
hemic and lymphatic diseases (10) 10
in-situ hybridization (10) 10
medicine, general & internal (10) 10
myeloma (10) 10
survival analysis (10) 10
translocations (10) 10
transplantation (10) 10
102 (9) 9
chromosome aberrations (9) 9
combination (9) 9
disease-free survival (9) 9
internal medicine (9) 9
medicine, research & experimental (9) 9
mice, transgenic (9) 9
models, biological (9) 9
mutations (9) 9
translocation (9) 9
translocation, genetic - genetics (9) 9
antineoplastic agents - pharmacology (8) 8
boronic acids - administration & dosage (8) 8
cell proliferation (8) 8
chromosomes, human, pair 14 (8) 8
cyclophosphamide - administration & dosage (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 09/2015, Volume 21, Issue 17 Supplement, pp. IA25 - IA25
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 10/2012, Volume 122, Issue 10, pp. 3456 - 3463
Multiple myeloma is a monoclonal tumor of plasma cells, and its development is preceded by a premalignant tumor with which it shares genetic abnormalities,... 
LIGHT-CHAIN RATIO | MEDICINE, RESEARCH & EXPERIMENTAL | RAS MUTATIONS | BONE-MARROW | GENE-EXPRESSION | PLASMA-CELL LEUKEMIA | MONOCLONAL GAMMOPATHY | KAPPA-B PATHWAY | FLOW-CYTOMETRY | UNDETERMINED SIGNIFICANCE MGUS | INDEPENDENT RISK-FACTOR | Precancerous Conditions - etiology | Translocation, Genetic | Monoclonal Gammopathy of Undetermined Significance - genetics | Humans | Neoplasm Proteins - physiology | Tumor Microenvironment | Oncogene Proteins, Fusion - physiology | Cyclin D1 - physiology | Neoplastic Stem Cells - pathology | Precancerous Conditions - pathology | Osteoclasts - physiology | Neoplasm Proteins - genetics | Retinoblastoma Protein - physiology | Stem Cell Niche | Genes, Retinoblastoma | Genes, bcl-1 | Monoclonal Gammopathy of Undetermined Significance - etiology | Immunophenotyping | Signal Transduction - genetics | Precancerous Conditions - genetics | Disease Progression | Drug Resistance, Neoplasm - genetics | Multiple Myeloma - etiology | Multiple Myeloma - pathology | Monoclonal Gammopathy of Undetermined Significance - pathology | Cell Transformation, Neoplastic | Models, Biological | Oncogene Proteins, Fusion - genetics | Signal Transduction - physiology | Bone Remodeling | Immunoglobulin Heavy Chains - genetics | Multiple Myeloma - genetics | Immunoglobulins | Gene mutations | Multiple myeloma | Physiological aspects | Genetic aspects | Research | Health aspects | Risk factors | Review Series
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 415 - 415
Abstract A genetic rearrangement of the MYC locus, resulting in dysregulated expression of MYC, is the most common mutation in human multiple myeloma (MM). The... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2005, Volume 23, Issue 26, pp. 6333 - 6338
Journal Article
Nature, ISSN 0028-0836, 02/2011, Volume 470, Issue 7332, pp. 124 - 129
Journal Article
Cell, ISSN 0092-8674, 2011, Volume 146, Issue 6, pp. 904 - 917
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 08/2019
The canonical plasma cell marker CD138 (syndecan-1) is highly expressed on the myeloma cell surface, but its functional role in vivo is unclear, as well as the... 
Journal Article
Nature Immunology, ISSN 1529-2908, 2008, Volume 9, Issue 12, pp. 1364 - 1370
The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-kappa B (NF-kappa B) signaling in resting cells by... 
MULTIPLE-MYELOMA | CD40 | IMMUNE-SYSTEM | CRITICAL ROLES | KINASE | RECEPTOR | ALPHA | NF-KAPPA-B2 P100 | IMMUNOLOGY | TNF | CELL-DEATH
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 18, pp. 4771 - 4779
Journal Article